Ensuring Access to Clinical Trials Act of 2015

Bill: 114-s-139
Sponsor: Sen. Wyden, Ron [D-OR]
Introduced: 2015-01-08 in the Senate
Policy area: Health
Subjects: Medicaid
Medical research
Poverty and welfare assistance

Summary:
action_date: 2015-01-08
text: 

Ensuring Access to Clinical Trials Act of 2015 

 
This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

action_date: 2015-07-16
text: 
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
 

Ensuring Access to Clinical Trials Act of 2015 

 
(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

action_date: 2015-09-28
text: 
(This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.)
 

Ensuring Access to Clinical Trials Act of 2015 

 
(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.

action_date: 2015-10-07
text: 
This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.) 

Ensuring Access to Clinical Trials Act of 2015 

 
(Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act, for eligibility purposes, of compensation in the amount of the first $2,000 per year received by individuals who participate in clinical trials for rare diseases or conditions.


Legislative actions:
action_date: 2015-10-07
text: Became Public Law No: 114-63.
action_date: 2015-10-07
text: Became Public Law No: 114-63.
action_date: 2015-10-07
text: Signed by President.
action_date: 2015-10-07
text: Signed by President.
action_date: 2015-09-30
text: Presented to President.
action_date: 2015-09-30
text: Presented to President.
action_date: 2015-09-28
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2015-09-28
text: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6276)
action_date: 2015-09-28
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6276)
action_date: 2015-09-28
text: DEBATE - The House proceeded with forty minutes of debate on S. 139.
action_date: 2015-09-28
text: Considered under suspension of the rules. (consideration: CR H6276-6279)
action_date: 2015-09-28
text: Mr. Ryan (WI) moved to suspend the rules and pass the bill.
action_date: 2015-07-24
text: Referred to the Subcommittee on Health.
action_date: 2015-07-21
text: Referred to the Subcommittee on Health.
action_date: 2015-07-20
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-07-20
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-07-20
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2015-07-20
text: Received in the House.
action_date: 2015-07-17
text: Message on Senate action sent to the House.
action_date: 2015-07-16
text: Passed Senate without amendment by Unanimous Consent. (consideration: CR S5175; text as passed Senate: CR S5175)
action_date: 2015-07-16
text: Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5175; text as passed Senate: CR S5175)
action_date: 2015-07-16
text: Senate Committee on Finance discharged by Unanimous Consent.
action_date: 2015-07-16
text: Senate Committee on Finance discharged by Unanimous Consent.
action_date: 2015-01-08
text: Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S105; text of measure as introduced: CR S105)
action_date: 2015-01-08
text: Introduced in Senate

Enacted as: number: 114-63